Julia Luthardt

Test–retest measurements of dopamine D1-type receptors using simultaneous PET/MRI imaging

Simon Kaller, Michael Rullmann, Marianne Patt et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2017 · 144 citations

Positron Emission Tomography, Neuroimaging Biomarkers, Medicine +9

PET Quantification of ¹⁸F-Florbetaben Binding to β-Amyloid Deposits in Human Brains

Georg Becker, Masanori Ichise, Henryk Barthel et al. · Journal of Nuclear Medicine · 2013 · 127 citations · Full text

Decreased cerebral α4β2* nicotinic acetylcholine receptor availability in patients with mild cognitive impairment and Alzheimer’s disease assessed with positron emission tomography

Kai Kendziorra, Henrike Wolf, Philipp Meyer et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2010 · 109 citations

Positron Emission Tomography, Neurodegenerative Diseases, Alzheimer's Disease +9

Central noradrenaline transporter availability in highly obese, non-depressed individuals

Swen Hesse, Georg‐Alexander Becker, Michael Rullmann et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2017 · 106 citations · Full text

Obesity, Metabolic Syndrome, Metabolic Disorder +7

Individualized quantification of brain β-amyloid burden: results of a proof of mechanism phase 0 florbetaben PET trial in patients with Alzheimer’s disease and healthy controls

Henryk Barthel, Julia Luthardt, Georg Becker et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2011 · 96 citations

Neurodegenerative Diseases, Alzheimer's Disease, Mechanism Phase 0 +9